• Overview
    • Why Invest
    • News
    • Events & Presentations
      • Events
      • Presentations
    • Stock Info
      • Stock Quote
      • Stock Chart
      • Analyst Coverage
    • Financials
      • Quarterly Results
      • SEC Filings
    • Governance
      • Governance Documents
      • Executive Management
      • Board of Directors
      • Committee Composition
    • Resources
      • Investor FAQs
      • Information Request Form
      • Investor Email Alerts
      • Investor Contacts
Skip to main content
Enfusion Logo Enfusion Logo

Board of Directors

  • Overview
    • Why Invest
    • News
    • Events & Presentations
      • Events
      • Presentations
    • Stock Info
      • Stock Quote
      • Stock Chart
      • Analyst Coverage
    • Financials
      • Quarterly Results
      • SEC Filings
    • Governance
      • Governance Documents
      • Executive Management
      • Board of Directors
      • Committee Composition
    • Resources
      • Investor FAQs
      • Information Request Form
      • Investor Email Alerts
      • Investor Contacts

Board Of Directors

Portrait

Michael Spellacy, Chair of the Board

Michael Spellacy joined Enfusion’s Board of Directors as Chair of the Board in early 2023. Spellacy currently serves as Chief Executive Officer and Director of Atlas Crest Investment Corp., Spellacy has extensive experience in technology, data and analytics, capital markets and private equity, and has worked as an investor, investment banker and consultant. Most recently, Spellacy was a Senior Managing Director at Accenture and Global Industry Leader of Accenture Capital Markets while overseeing Accenture’s Asset Management, Wealth Management and Investment and Trading businesses. Prior to Accenture, Spellacy was a Senior Partner, Asset and Wealth Management, at PricewaterhouseCoopers from 2015 to 2017.

Spellacy received his B.S. in Economics from the London School of Economics and MBA from the University of Hartford.

Brad Bernstein

Brad Bernstein is Managing Partner of FTV Capital, a sector-focused growth equity investment firm. He has over 30 years of private equity experience.

Prior to FTV Capital, Bernstein was a partner at Oak Hill Capital Management and its predecessors, where he managed the business and financial services group. He held roles at Patricof & Company Ventures and in the investment banking division of Merrill Lynch. He holds a bachelor’s degree magna cum laude from Tufts University.

Portrait

Kathleen DeRose

Kathleen DeRose is a Clinical Associate Professor of Finance at the Stern School of Business at New York University, focusing on FinTech. In addition, she is the Director of NYU’s Fubon Center for Technology, Business, and Innovation and a non-executive director of the London Stock Exchange Group and Voya Financial.

DeRose previously served as Chairman of the Board of Evolute, as Managing Director at Credit Suisse, Bessemer Trust, Scudder Stevens & Clark, and as VP at JPMorgan Chase.

Jan Hauser

Jan Hauser is an experienced board member and global finance leader. Jan serves on the Vonage board of directors and is also a member of Women Corporate Directors and the Northeast Audit Committee Network.

Previously, Hauser held senior roles at GE and PwC. She represented PwC on the FASB’s Emerging Issues Task Force and Financial Accounting Standards Advisory Council, and worked in the Office of the Chief Accountant at the SEC. She graduated from the University of Wisconsin and is a licensed CPA.

Larry Leibowitz

Larry Leibowitz is an experienced finance and technology entrepreneur. He serves on the Board of Directors of Cowen, Inc., an independent investment bank, and several private companies.

Leibowitz served as Chief Operating Officer, Head of Global Equities Markets and Board Director of NYSE Euronext from 2007 to 2013. He started his career at Morgan Stanley and holds a bachelor’s degree summa cum laude in Economics from Princeton University.

Portrait

Roy Luo

Roy Luo has been a member of Enfusion’s board of directors since 2021 and a member of the board of managers of Enfusion Ltd. LLC since December 2020.

Luo has also served as an investor at ICONIQ Capital since April 2018, and was previously an investor at Technology Crossover Ventures. He holds a bachelor’s degree from Yale University.

Portrait

Oleg Movchan

Oleg Movchan holds leadership and advisory roles at Revolution Global, Gimel Tech Ventures, Quiet Light Partners, and Kameosa Capital, LLC. He previously served in risk leadership roles at several hedge funds and asset management firms.

Movchan is a graduate of the General Management Program from the Aresty Institute of Executive Education at the Wharton School. He holds a Master of Science degree and an MBA from the University of Chicago and a master’s degree from Kharkiv State University (Ukraine).

Portrait

Deirdre Somers

Deirdre Somers is an experienced asset management industry executive, having spent her more than 30-year career as the former CEO of a securities exchange and as an independent non-executive director, committee member, and chairman, among other roles. Somers has both international experience and industry knowledge in financial products, market structure, and EU regulation, as well as in corporate actions and public market transitions.

Somers is currently an independent non-executive director (INED) and committee member of Aquis Exchange PLC, Blackrock iShares, Cancer Trials Ireland (Chair), Episode Inc, and Kenmare Resources plc.

Quick Links

  • SEC Filings
  • Investor FAQs
  • Information Request Form
  • Corporate Governance

Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Enfusion, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Enfusion to send you the requested Investor Email Alert updates.

* Required

*
Investor Alert Options
*





Unsubscribe

Email Alert Sign Up Confirmation

REQUEST A MEETING WITH MANAGEMENT >
Enfusion Logo

Contact Us

Ignatius Njoku

Executive Director, Head of Investor Relations
investors@enfusion.com

  • Overview
    • Why Invest
    • News
    • Events & Presentations
    • Stock Info
    • Financials
    • Governance
    • Resources
  • Privacy Policy
  • Terms and conditions
© Enfusion Ltd. - All rights reserved
Powered By Q4 Inc. 5.87.0.1 (opens in new window)